Although the covid pandemic mitigations have been challenging, they have resulted in a perspective adjustment at MSACL that has revealed an exciting opportunity to extend the
knowledge base of the MSACL community even further into the research and clinical space ... consistent online content.
Under this new paradigm of operation, we are offering a platform of engagement to provide not only classical SCIENTIFIC CONTENT, but also to extend
the best of the MSACL NETWORKING effects -- such as those found during Booth and Poster Tours, and the Meet-a-Mentor program -- into the virtual space. SHORT COURSES are also a part of the Connect ecosystem.
Thu
Aug
18, 2022
Los Angeles : 09:00 AM - 10:00 AM
NEW YORK:
Aug 18 • 12:00 PM - 01:00 PM
LONDON:
Aug 18 • 05:00 PM - 06:00 PM
PARIS:
Aug 18 • 06:00 PM - 07:00 PM
INDIA:
Aug 18 • 09:30 PM - 10:30 PM
CHINA:
Aug 19 • 12:00 AM - 01:00 AM
SYDNEY:
Aug 19 • 02:00 AM - 03:00 AM
Seminar
Supported by an Open Unrestricted Educational Grant
provided by
There is no cost to register for this activity.
Jennifer Van Eyk, PhD
Cedars-Sinai Heart Institute
Jennifer Van Eyk, PhD, is an international leader in the area of clinical proteomics and her lab has focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. This includes multiple reaction monitoring (MRM, also known as SRM) and most recently data independent acquisition. Dr. Van Eyk's laboratory is well known for the extreme technical quality of the data generated, rigorous quality control with tight %CV while applying these to key clinical questions. The aim is to maximize throughput and reproducibility in order to move targeted and robust discovery methods into large population healthy continuous assessment and clinical grade assays focusing on brain and cardiovascular diseases.